Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004684-31Phase 2Completed
Phase 2, randomised trial of sodium selenite in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Plasma selenium levels. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004684-31.